Skip to content

Comparative investigation between the effectiveness of Salvia officinalis extract and Cognitive remediation therapy on cognitive function in menopausal women

Comparative investigation between the effectiveness of Salvia officinalis extract and Cognitive remediation therapy on cognitive function in menopausal women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20201027049164N3
Enrollment
90
Registered
2021-10-07
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cognitive function impairment. Mild cognitive impairment, so stated

Interventions

Intervention 1: Intervention group 1:The counseling group will receive 8 sessions of 90 minutes, one session per week as a group of cognitive rehabilitation counseling. Intervention 2: Intervention gr

Sponsors

Kerman University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
45 Years to 65 Years

Inclusion criteria

Inclusion criteria: Iranian women 45 to 65 years old Cutting menstruation for at least one year Minimum literacy reading and writing Lack of sensitivity to herbal medicines No addiction or smoking Lack of any known physical illnesses such as epilepsy and vascular and renal and liver diseases Lack of any significant psychiatric disorders of anxiety and depression and significant psychiatric neurological symptoms Do not use any drugs that affect memory and cognitive function Having a personal desire and conscious satisfaction to participate in the study Do not take any phytoestrogen herbal medicine for three months before the intervention No infection or no history of breast or vaginal cancer Absence of severe cognitive disorders (Alzheimer's and dementia)

Exclusion criteria

Exclusion criteria: Symptoms of drug allergy Taking any medication while conducting research Existence of severe stress during treatment Absence of more than two sessions in counseling sessions Has taken less than 85% of the drug Acute and chronic diseases infection during the study

Design outcomes

Primary

MeasureTime frame
Cognitive function. Timepoint: Beginning of the study (before the start of the intervention) and end of the intervention. Method of measurement: Montreal Cognitive Assessment Questionnaire (MOCA).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohadese Yazdani

Kerman University of Medical Sciences

mohadese.yzd22@gmail.com+98 34 3132 5700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026